Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
William Camara
Institution:
Foundation Medicine (United States)
Observed institution:
Foundation Medicine (United States)
ORCID:
0009-0008-0715-1545
Observed ORCID:
0009-0008-0715-1545
OpenAlex ID:
A5010856320
Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors
2024
·
Daniel R. Zollinger
, Elizabeth Rivers
, et al.
·
PLoS ONE
·
15
Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial.
2023
·
Jonathan M. Loree
, Russell Madison
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Detection of Molecular Residual Disease by Circulating Tumor DNA in Early-Stage Node-Negative Rectal Cancers (CCTG CO.28) Using a Tumor-Informed Assay
2025
·
Jonathan M. Loree
, Emma Titmuss
, et al.
·
JCO oncology advances.
·
1
PDF
LINE-1 retrotransposition is a recurrent cause of MET exon 14 skipping in cancer
2026
·
Jennifer A. Karlow
, Callan O’Connor
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
4
Citation count:
18
H-index:
2
I10-index:
1
Year
Topic
Type